Lei Yang

机构：Guiyang Medical University, Shandong University, Anhui Medical University, Nantong University, Sichuan University, Affiliated Hospital of Nantong University, Panzhihua University, Affiliated Hospital of Guizhou Medical University, Ingenierie des Materiaux polymeres, First Hospital of Lanzhou University, Lanzhou University, South China University of Technology · ORCID：0000-0001-5386-8434

发表论文 108 篇 · 总被引 1070 次 · h-index 18

代表论文

• KRTCAP2 as an immunological and prognostic biomarker of hepatocellular carcinoma (2023 · Colloids and Surfaces B Biointerfaces · 被引 31)
• The efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer patients: a systematic review (2024 · Frontiers in Immunology · 被引 25)
• Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis (2023 · Applied Biochemistry and Biotechnology · 被引 19)
• Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma (2023 · EClinicalMedicine · 被引 16)
• Generating Topologically Consistent BIM Models of Utility Tunnels from Point Clouds (2023 · Sensors · 被引 12)
• Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma (2024 · American Journal Of Pathology · 被引 9)